{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:29:58Z","timestamp":1790504998758,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Inserm","doi-asserted-by":"crossref","award":["UMR-S 1171"],"award-info":[{"award-number":["UMR-S 1171"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015872","name":"University of Lille","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015872","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Adrinord"},{"name":"University Caen-Normandie"},{"name":"FP7 Eranet-Neuron","award":["Eranet-NEURON 3-275-006"],"award-info":[{"award-number":["Eranet-NEURON 3-275-006"]}]},{"name":"French Ministry of Health","award":["PHRC"],"award-info":[{"award-number":["PHRC"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00415-018-8827-6","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T11:51:58Z","timestamp":1521201118000},"page":"1166-1173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke"],"prefix":"10.1007","volume":"265","author":[{"name":"The OPHELIE Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixtine","family":"Gilliot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Sibon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"B\u00e9jot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Giroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Odou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Bordet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Vivien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4408-4392","authenticated-orcid":false,"given":"Didier","family":"Leys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"8827_CR1","first-page":"35","volume":"18","author":"H Panahpour","year":"2010","unstructured":"Panahpour H, Dehghani GA (2010) Inhibition of central angiotensin-converting enzyme with enalapril protects the brain from ischemia\/reperfusion injury in normotensive rat. DARU 18:35\u201340","journal-title":"DARU"},{"key":"8827_CR2","doi-asserted-by":"publisher","first-page":"e23646","DOI":"10.1371\/journal.pone.0023646","volume":"6","author":"C Thoene-Reineke","year":"2011","unstructured":"Thoene-Reineke C, Rumsch\u00fcssel K, Schmerbach K et al (2011) Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models. PLoS One 6:e23646","journal-title":"PLoS One"},{"key":"8827_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/jnnp-2014-308948","volume":"86","author":"J Sundb\u00f8ll","year":"2015","unstructured":"Sundb\u00f8ll J, Schmidt M, Horv\u00e1th-Puh\u00f3 E et al (2015) Preadmission use of ACE inhibitors or angiotensin receptor blockers and short-term mortality after stroke. J Neurol Neurosurg Psychiatry 86:748\u2013754","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8827_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","volume":"126","author":"PS Roshanov","year":"2017","unstructured":"Roshanov PS, Rochwerg B, Patel A et al (2017) Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patIents cOhort evaluatioN Prospective Cohort. Anesthesiology 126:16\u201327","journal-title":"Anesthesiology"},{"key":"8827_CR5","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1212\/WNL.0000000000003399","volume":"87","author":"D Leys","year":"2016","unstructured":"Leys D, Hommet Y, Jacquet C et al (2016) Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke. Neurology 87:2416\u20132426","journal-title":"Neurology"},{"key":"8827_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.neurol.2017.03.023","volume":"173","author":"A Decourcelle","year":"2017","unstructured":"Decourcelle A, Moulin S, Dequatre-Ponchelle N et al (2017) Are the results of intravenous thrombolysis trials reproduced in clinical practice? Comparison of observed and expected outcomes with the stroke-thrombolytic predictive instrument (STPI). Rev Neurol (Paris) 173:381\u2013387","journal-title":"Rev Neurol (Paris)"},{"issue":"Suppl 4","key":"8827_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000047587","volume":"10","author":"C Cordonnier","year":"2000","unstructured":"Cordonnier C, Girot M, Dorp E et al (2000) Stroke units from scientific evidence to practice: the experience of the Lille stroke unit. Cerebrovasc Dis 10(Suppl 4):17\u201320","journal-title":"Cerebrovasc Dis"},{"key":"8827_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1474-4422(07)70036-4","volume":"6","author":"K Vahedi","year":"2007","unstructured":"Vahedi K, Hofmeijer J, J\u00fcttler E et al (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6:215\u2013222","journal-title":"Lancet Neurol"},{"key":"8827_CR9","first-page":"141217070022009","volume":"372","author":"OA Berkhemer","year":"2014","unstructured":"Berkhemer OA, Fransen PSSS, Beumer D et al (2014) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372:141217070022009","journal-title":"N Engl J Med"},{"key":"8827_CR10","doi-asserted-by":"crossref","unstructured":"The European Stroke Organisation (ESO) executive committee, Ringleb PA, Bousser M-G, et al (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25:457\u2013507 (see update at\u202f: http:\/\/www.eso-stroke.org","DOI":"10.1159\/000131083"},{"key":"8827_CR11","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke W, Kaste M, Fieschi C et al (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352:1245\u20131251","journal-title":"Lancet"},{"key":"8827_CR12","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1161\/01.STR.0000185725.42768.92","volume":"36","author":"P Lyden","year":"2005","unstructured":"Lyden P, Raman R, Liu L et al (2005) NIHSS training and certification using a new digital video disk is reliable. Stroke 36:2446\u20132449","journal-title":"Stroke"},{"key":"8827_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC Swieten van","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC et al (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604\u2013607","journal-title":"Stroke"},{"key":"8827_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35\u201341","journal-title":"Stroke"},{"key":"8827_CR15","first-page":"46","volume":"72","author":"RB Bendel","year":"1977","unstructured":"Bendel RB, Afifi AA (1977) Comparison of stopping rules in forward regression. J Am Stat Ass 72:46\u201353","journal-title":"J Am Stat Ass"},{"key":"8827_CR16","volume-title":"Primer of applied regression and analysis of variance","author":"SA Glantz","year":"1990","unstructured":"Glantz SA, Slinker BK (1990) Primer of applied regression and analysis of variance. McGraw Hill, New York"},{"key":"8827_CR17","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1161\/STROKEAHA.116.013334","volume":"47","author":"F Myslimi","year":"2016","unstructured":"Myslimi F, Caparros F, Dequatre-Ponchelle N et al (2016) Orolingual angioedema during or after thrombolysis for cerebral ischemia. Stroke 47:1825\u20131830","journal-title":"Stroke"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-8827-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8827-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8827-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T04:37:35Z","timestamp":1589863055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-8827-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["8827"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-8827-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,16]]},"assertion":[{"value":"2 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Jean-Louis Mas, Charlotte Cordonnier, and Didier Leys are investigators of ECASS4 (no honoraria). Didier Leys has been member of scientific advisory boards and symposia for Boehringer-Ingelheim (fees paid to ADRINORD). Sixtine Gilliot, Igor Sibon, Thierry Moulin, Yannick Bejot, Maurice Giroud, Pascal Odou, R\u00e9gis Bordet, and Denis Vivien, declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by French health authorities and by the relevant ethical committee (Comit\u00e9 de Protection des Personnes Nord Ouest IV Lille, France) by March 9th, 2010, under registration number 10.677.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients gave informed consent themselves or via a close relative.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}